Quantcast

Latest Boehringer Ingelheim Stories

2014-03-28 08:27:23

Cardiologists also believe their patients' top concern is the fear of experiencing a clot that leads to a stroke; real-world challenges may influence treatment decisions RIDGEFIELD, Conn., March 28, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced results from a new survey of cardiologists to understand their perceptions about anticoagulation, stroke risk reduction and goals for non-valvular atrial fibrillation (NVAF) therapy when prescribing warfarin or...

2014-03-24 20:23:52

DUBLIN, March 25, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/skgh5l/investigation) has announced the addition of the "Investigation Report on China Telmisartan Market" [http://www.researchandmarkets.com/research/skgh5l/investigation ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) According to statistics from WHO, one-third of the world's adults have high blood pressure. Death toll...

2014-03-24 08:28:21

Presentations to include research around antidote for dabigatran, a post-hoc analysis of data from the RE-LY® trial and data from the GLORIA(TM)-AF registry RIDGEFIELD, Conn., March 24, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that data from three company-sponsored PRADAXA studies will be presented at the American College of Cardiology 63(rd) Annual Scientific Session (ACC.14) in Washington, D.C., March 29 to 31, 2014. An oral presentation will...

2014-03-22 23:04:44

A new lawsuit was filed on March 19, by a widow in Pennsylvania Eastern District Court alleging that her husband died from renal failure and intracerebral hemorrhage caused by Pradaxa. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Pradaxa side effects. San Diego, CA (PRWEB) March 21, 2014 AttorneyOne.com, a recognized authority on law,...

2014-03-21 08:24:55

Positive opinion is based on data from one of the largest clinical registration programs in its class, involving more than 13,000 adults with type 2 diabetes RIDGEFIELD, Conn. and INDIANAPOLIS, March 21, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE: LLY) today announced a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency, recommending approval of empagliflozin, an...

2014-03-20 23:33:37

Pharmica Consulting, the industry leader in life science processes and technology, is pleased to announce that John Olszewski of Boehringer Ingelheim USA will speak at Pharmica’s SharePoint Conference for the Life Sciences Industry on June 4th and 5th in Plymouth Meeting, PA. Plymouth Meeting, PA (PRWEB) March 20, 2014 As part of its continued service to the industry, Pharmica will host its 10th SharePoint conference in Plymouth Meeting, PA on June 4-5, 2014. The two day conference will...

2014-03-19 23:31:58

According to a Court Order filed in March 13, new sanctions were imposed on Boehringer Ingelheim for Pradaxa Multidistrict Litigation discovery abuses. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Pradaxa side effects. San Diego, CA (PRWEB) March 19, 2014 AttorneyOne.com, a recognized authority on law, updated the website recently and now,...

2014-03-13 23:26:43

Roger C. Denton, Plaintiffs' Co-Lead Counsel in the Pradaxa® MDL, provides an update on the Pradaxa® Multidistrict Litigation (MDL 2385), particularly that the first trial is now set to begin this fall. St. Louis, MO (PRWEB) March 13, 2014 The first trial in the Pradaxa® Multidistrict Litigation entitled In re: Pradaxa® (Dabigatran Etexilate) Products Liability Litigation (MDL 2385, Case No. 12-md-2385) is set to begin this fall in the United States District Court...

2014-03-11 23:30:43

http://www.DrugNews.net is the web’s premier source for prescription device warnings, research, side effects and legal news. Visit the DrugNews Center today. New York, NY (PRWEB) March 11, 2014 The prescription drug safety center DrugNews.net is announcing new information on the site about the blood thinner Pradaxa. A new report shows the Food and Drug Administration of Jordan recently approved the popular drug, marking the 100th country to authorize its use*. DrugNews is a free...

2014-03-11 23:27:48

Pharmica Consulting, the industry leader in life science processes and technology, is pleased to announce that Stephan Klaschka, Director, Global Innovation Strategy of Boehringer Ingelheim will be speaking at Pharmica’s “Pharma 3.0 – The Digital Medicine Era” conference to be held April 30th & May 1st, 2014 in Conshohocken, PA. Conshohocken, PA (PRWEB) March 11, 2014 The transition to a services and outcome focus is underway in healthcare. Digital medicine provides the...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related